Showing results (691-700 of 7,022) with videos related to
Sort By:
Pageof 703
American Journal of Hypertension|July 1, 1994
Immunization of Dahl SS/jr rats with an ouabain conjugate mitigates hypertensionE P Gomez-Sanchez, C E Gomez-Sanchez, C FortAmerican Journal of Hypertension|July 1, 1994
Effects of angiotensin II on insulin sensitivity and fasting glucose metabolism in ratsR H RaoAmerican Journal of Hypertension|July 1, 1994
Effects of isradipine on endothelin-induced constriction of myometrial arteries in normotensive pregnant womenK R Kublickiene, K Wolff, M Kublickas, et al.American Journal of Hypertension|August 1, 1993
Effect of cytokines on cytosolic-free calcium in human platelets from essential hypertensivesM Tepel, H Wischniowski, M Neusser, et al.American Journal of Hypertension|August 1, 1993
Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertensionH C Gonick, E W Weiler, F Khalil-Manesh, et al.American Journal of Hypertension|August 1, 1993
Chronic ethanol treatment increases the circulating plasma levels of B-type natriuretic peptide (BNP-45) in the ratD A Wigle, S C Pang, J D Watson, et al.American Journal of Hypertension|July 1, 1997
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderlyM Monane, R L Bohn, J H Gurwitz, et al.American Journal of Hypertension|July 1, 1997
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study GroupB Dahlöf, R Devereux, U de Faire, et al.American Journal of Hypertension|July 1, 1997
Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertensionP Chan, C N Lin, B Tomlinson, et al.American Journal of Hypertension|July 1, 1997
Effects of cicletanine on prostaglandin I2 and E2 levels in patients with essential hypertensionT Yasu, M ImanishiPageof 703